• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于灭活肠道病毒71型疫苗研发的微载体细胞培养工艺优化

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.

作者信息

Wu Suh-Chin, Liu Chia-Chyi, Lian Wei-Cheng

机构信息

Department of Life Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan.

出版信息

Vaccine. 2004 Sep 28;22(29-30):3858-64. doi: 10.1016/j.vaccine.2004.05.037.

DOI:10.1016/j.vaccine.2004.05.037
PMID:15364432
Abstract

Enterovirus 71 (EV71) is an enterovirus that could lead to severe neurological disorders and fatalities. The inactivated vaccine is an appropriate EV71 vaccine format for meeting current needs. Large-scale preparation of the inactivated EV71vaccine depends on a scalable cell culture system for industrial mass production. In this paper, Vero cells were found to produce higher titers of EV71 than did MRC-5 and WI-38 cells. High-density microcarrier Vero cell cultures were established using 5g/L Cytodex 1 microcarriers and found to promote the release of EV71s from infected Vero cells. For the large-scale production of the inactivated vaccine antigen, the extracellular virus titers produced in the 2L bioreactor were found to be 10 times lower than the spinner flask culture but improved by 30-folds using glucose/glutamine feedings during infection. A serum-free Vero cell microcarrier culture was also established in the bioreactor, yielding a high-titer of 5.8 x 10(7) TCID50/mL for EV71 production. The immunogenicity of the inactivated virions produced in serum-free culture elicited a slightly higher level of neutralizing antibody response in immunized mice. These results constitute valuable information on the development of a large-scale microcarrier cell culture process for producing inactivated EV71 vaccine.

摘要

肠道病毒71型(EV71)是一种可导致严重神经紊乱和死亡的肠道病毒。灭活疫苗是满足当前需求的一种合适的EV71疫苗形式。大规模制备灭活EV71疫苗依赖于用于工业大规模生产的可扩展细胞培养系统。在本文中,发现Vero细胞产生的EV71滴度高于MRC-5和WI-38细胞。使用5g/L Cytodex 1微载体建立了高密度Vero细胞微载体培养物,发现其可促进感染的Vero细胞释放EV71。对于大规模生产灭活疫苗抗原,发现2L生物反应器中产生的细胞外病毒滴度比转瓶培养低10倍,但在感染期间通过葡萄糖/谷氨酰胺补料提高了30倍。还在生物反应器中建立了无血清Vero细胞微载体培养物用于生产EV71,其滴度高达5.8×10⁷ TCID₅₀/mL。无血清培养产生的灭活病毒颗粒的免疫原性在免疫小鼠中引发了略高水平的中和抗体反应。这些结果为开发用于生产灭活EV71疫苗的大规模微载体细胞培养工艺提供了有价值的信息。

相似文献

1
Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.用于灭活肠道病毒71型疫苗研发的微载体细胞培养工艺优化
Vaccine. 2004 Sep 28;22(29-30):3858-64. doi: 10.1016/j.vaccine.2004.05.037.
2
High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.高免疫原性肠道病毒71型毒株及其利用无血清微载体Vero细胞培养的生产方法。
Vaccine. 2007 Jan 2;25(1):19-24. doi: 10.1016/j.vaccine.2006.06.083. Epub 2006 Aug 2.
3
Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.200升规模无血清微载体生物反应器系统生产的灭活肠道病毒71型疫苗在人SCARB2转基因小鼠中提供交叉保护效力。
PLoS One. 2015 Aug 19;10(8):e0136420. doi: 10.1371/journal.pone.0136420. eCollection 2015.
4
Identification and characterization of a cross-neutralization epitope of Enterovirus 71.鉴定和表征肠道病毒 71 的交叉中和表位。
Vaccine. 2011 Jun 10;29(26):4362-72. doi: 10.1016/j.vaccine.2011.04.010. Epub 2011 Apr 16.
5
Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.微载体融合生物反应器培养提高肠道病毒 A71 疫苗产量。
Vaccine. 2018 May 24;36(22):3134-3139. doi: 10.1016/j.vaccine.2017.02.042. Epub 2017 Mar 6.
6
Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.建立动物攻毒模型作为灭活肠道病毒71型疫苗的效力测定方法。
Biologicals. 2016 Jul;44(4):183-190. doi: 10.1016/j.biologicals.2016.01.003. Epub 2016 Apr 8.
7
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.规模化生产高效且稳定的肠道病毒 71 型疫苗候选株。
PLoS One. 2012;7(4):e34834. doi: 10.1371/journal.pone.0034834. Epub 2012 Apr 17.
8
Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.一种适用于作为候选疫苗的肠道病毒71型Vero细胞适应毒株的特性分析。
Vaccine. 2002 Jun 7;20(19-20):2485-93. doi: 10.1016/s0264-410x(02)00182-2.
9
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.一项评估肠道病毒 71 型疫苗的安全性和免疫原性的 I 期、随机、开放标签研究。
Vaccine. 2013 May 7;31(20):2471-6. doi: 10.1016/j.vaccine.2013.03.015. Epub 2013 Mar 27.
10
Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.一种模拟80S空衣壳的工程肠道病毒71型样颗粒疫苗的结构、免疫原性及保护机制
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01330-17. Print 2018 Jan 1.

引用本文的文献

1
A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigella.一种三维高通量检测方法鉴定出了对细胞内志贺氏菌具有活性的新型抗菌分子。
NPJ Antimicrob Resist. 2025 May 15;3(1):40. doi: 10.1038/s44259-025-00110-6.
2
Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach.推断基于B细胞衍生T细胞受体诱导的多表位肠道病毒71型候选疫苗:一种反向疫苗学方法。
Clin Exp Vaccine Res. 2024 Apr;13(2):132-145. doi: 10.7774/cevr.2024.13.2.132. Epub 2024 Apr 30.
3
Seed Train Optimization in Microcarrier-Based Cell Culture Post In Situ Cell Detachment through Scale-Down Hybrid Modeling.
基于微载体的细胞培养中通过缩小混合建模进行原位细胞脱离后的种子列车优化。
Bioengineering (Basel). 2024 Mar 9;11(3):268. doi: 10.3390/bioengineering11030268.
4
High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors.在搅拌罐生物反应器中进行高滴度严重急性呼吸综合征冠状病毒2刺突蛋白假型水疱性口炎病毒的生产。
Mol Ther Methods Clin Dev. 2024 Jan 17;32(1):101189. doi: 10.1016/j.omtm.2024.101189. eCollection 2024 Mar 14.
5
Glutathione affinity chromatography for the scalable purification of an oncolytic virus immunotherapy from microcarrier cell culture.用于从微载体细胞培养物中可扩展纯化溶瘤病毒免疫疗法的谷胱甘肽亲和色谱法。
Front Bioeng Biotechnol. 2023 Jun 15;11:1193454. doi: 10.3389/fbioe.2023.1193454. eCollection 2023.
6
Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.无血清 HEK293A 细胞培养系统中柯萨奇病毒 A10 的增殖和免疫特性。
Virus Res. 2023 May;329:199101. doi: 10.1016/j.virusres.2023.199101. Epub 2023 Mar 24.
7
Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development.用于灭活柯萨奇病毒A16疫苗开发的一次性生物反应器中聚合物纤维载体上培养的Vero细胞的优化。
Vaccines (Basel). 2021 Jun 7;9(6):613. doi: 10.3390/vaccines9060613.
8
Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors.在 CelCradle™ -500A 生物反应器中生产小反刍兽疫病毒、裂谷热病毒和牛结节性皮肤病病毒。
BMC Vet Res. 2021 Feb 27;17(1):93. doi: 10.1186/s12917-021-02801-4.
9
Vero cell upstream bioprocess development for the production of viral vectors and vaccines.用于生产病毒载体和疫苗的vero 细胞上游生物工艺开发。
Biotechnol Adv. 2020 Nov 15;44:107608. doi: 10.1016/j.biotechadv.2020.107608. Epub 2020 Aug 5.
10
Process optimization for the rapid production of Enterovirus 71.肠道病毒71型快速生产的工艺优化
Cytotechnology. 2019 Dec;71(6):1053-1061. doi: 10.1007/s10616-019-00340-3. Epub 2019 Sep 26.